Jump to content

Xtandi (Enzalutamide) before chemo PBAC decision due to be published 21 April 2017


Recommended Posts

Last Friday 10 March 2017 the Pharmaceutical Benefits Advisory Committee (PBAC) reached its initial decisions on drugs to go onto the PBS at reduced prices. 

This included whether to put Xtandi (Enzalutamide) before chemo on the PBS.

The company will be told of the result next Friday 17 March 2017.

If necessary, negotiations between the PBAC and the company continue for 4 weeks. 

The final results will be published on the PBAC website 21 April 2017.

(If the company is not happy with the result, they have until July 2017 to appeal.)


Link to comment
Share on other sites

  • Admin locked this topic


This topic is now archived and is closed to further replies.

This topic is now closed to further replies.
  • Create New...